Evaluating the reliability and construct validity of the Eckardt symptom score as a measure of achalasia severity

T. H. Taft*, D. A. Carlson, J. Triggs, J. Craft, K. Starkey, R. Yadlapati, D. Gregory, J. E. Pandolfino

*Corresponding author for this work

Research output: Contribution to journalArticle

13 Scopus citations

Abstract

Background: Achalasia is a disease of mechanical esophageal dysfunction characterized by dysphagia, chest pain, regurgitation, and malnutrition. The Eckardt symptom score (ESS) is the gold standard self-report assessment tool. Current guidelines outline a three-step approach to patient reported outcomes measure design. Developed prior to these policies, the ESS has not undergone rigorous testing of its reliability and validity. Methods: Adult achalasia patients retrospectively identified via a patient registry were grouped based on treatment history. Patients were grouped PREPOST (completed ESS, GERDQ, brief esophageal dysphagia questionnaire, NIH PROMIS Global Health, high resolution manometry, timed barium esophagram prior to treatment and after) and POST (completed measures only after treatment). Clinical characteristics, treatment type and date were obtained via medical record. Standardized psychometric analyses for reliability and construct validity were performed. Key Results: 107 patients identified; 83 POST and 24 PREPOST. The ESS has fair internal consistency and split-half reliability with a single factor structure. Dysphagia accounts for half the variance in ESS, while chest pain and weight loss account for 10% each. Pre-post-surgical assessment demonstrates improvements in ESS, except for weight loss. Effect sizes range from 0.24 to 2.53, with greatest change in regurgitation. Validity of the ESS is supported by modest correlations with GERDQ, HRQOL, and physiological data. Conclusions & Inferences: The ESS demonstrates fair reliability and validity, with a single factor structure mostly explained by dysphagia. Based on psychometric findings, weight loss and chest pain items may be decreasing ESS reliability and validity. Further assessment of the ESS under FDA guidelines is warranted.

Original languageEnglish (US)
Article numbere13287
JournalNeurogastroenterology and Motility
Volume30
Issue number6
DOIs
StatePublished - Jun 2018

Keywords

  • Eckardt symptom score
  • achalasia
  • patient reported outcomes

ASJC Scopus subject areas

  • Physiology
  • Endocrine and Autonomic Systems
  • Gastroenterology

Fingerprint Dive into the research topics of 'Evaluating the reliability and construct validity of the Eckardt symptom score as a measure of achalasia severity'. Together they form a unique fingerprint.

  • Cite this